Jeffrey Keisling - Fierce's Top 10 Biotech Techies

Big Pharma IT agent

Name: Jeffrey Keisling
Title: Senior vice president and chief information officer
Company: Pfizer

Jeffrey Keisling has made information technology a key factor in a business transformation under way at Pfizer ($PFE). The CIO of the world's largest drugmaker, Keisling has had the tricky task of finding IT strategies that support Pfizer's evolving business model, which has taken shape to withstand the turmoil in the biopharma industry.

Pfizer, whose R&D organization has suffered many setbacks over the years, has boosted its dependence on a vast network of external partners to help the company bring new products to market efficiently. Keisling has garnered kudos for providing the company's scientists and business leaders the tools to tackle the monumental challenges that the industry faces.

For instance, his team has provided the company with a virtual R&D system that has helped the company embrace open innovation, according to CIO magazine, and Keisling has dispatched IT aces with business acumen to serve in Pfizer's different divisions. These efforts have made the Pfizer organization more IT-driven than merely IT-supported.

Keisling was one of the senior executives from Wyeth who made the cut after the $67 billion merger of the company and Pfizer in 2009, with Keisling becoming the lead player in integrating the IT aspects of each organization's massive enterprises.

Jeffrey Keisling - Fierce's Top 10 Biotech Techies

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.